811 results on '"Cornel, Martina C"'
Search Results
2. The impact of counselors’ values and religious beliefs on their role identity and perspectives on heritable genome editing: a qualitative interview study
3. Dealing with ambivalence in the practice of advanced genetic healthcare: towards an ethical choreography
4. Perceptions of reproductive healthcare providers regarding their involvement in offering expanded carrier screening in fertility clinics: a qualitative study
5. Improving care for rare genetic neurodevelopmental disorders: A systematic review and critical appraisal of clinical practice guidelines using AGREE II
6. Should secondary pharmacogenomic variants be actively screened and reported when diagnostic genome-wide sequencing is performed in a child?
7. The impact of the Journal of Community Genetics: Good Health and Wellbeing, Quality Education, and Reduced Inequalities
8. Effectiveness of L-serine supplementation in children with a GRIN2B loss-of-function mutation: Rationale and protocol for single patient (n-of-1) multiple cross-over trials
9. New year, new goals for the journal?
10. Chapter 2 Risk Calculations in Consanguinity
11. Roles and Responsibilities of Stakeholders in Informing Healthy Individuals on Their Genome: A Sociotechnical Analysis
12. Identification of Organisational Models for the Provision of Predictive Genomic Applications
13. Engagement of patients and the public in personalised prevention in Europe using genomic information: a scoping review.
14. Corrigendum to Effectiveness of L-serine supplementation in children with a GRIN2B loss-of-function mutation: Rationale and protocol for single patient (n-of-1) multiple cross-over trials. Contemp Clin Trials Commun. 36 (2023) Pages not provided/ DOI: 10.1016/j.conctc.2023.101233
15. Reproductive healthcare providers’ perceptions regarding their involvement in offering expanded carrier screening in fertility clinics: a qualitative study
16. Genetic Health Care Before Conception
17. Moving somatic gene editing to the clinic: routes to market access and reimbursement in Europe
18. Couples’ experiences with expanded carrier screening: evaluation of a university hospital screening offer
19. 2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families
20. Neonatal and carrier screening for rare diseases: how innovation challenges screening criteria worldwide
21. Genetic Screening—Emerging Issues.
22. Costs, burdens and the prevention of genetic disorders: what role for professional influence?
23. How will new genetic technologies, such as gene editing, change reproductive decision-making? Views of high-risk couples
24. Should Secondary Pharmacogenomic Variants Be Actively Screened and Reported When Diagnostic Genome-Wide Sequencing Is Performed in a Child?
25. How to Integrate Personalized Medicine into Prevention? Recommendations from the Personalized Prevention of Chronic Diseases (PRECeDI) Consortium
26. Identification of Organisational Models for the Provision of Predictive Genomic Applications
27. Roles and Responsibilities of Stakeholders in Informing Healthy Individuals on Their Genome: A Sociotechnical Analysis
28. Genomic medicine in 2025–2030
29. In memoriam Prof. Dr. Leo P. ten Kate
30. Information Provision Regarding Health-Related Direct-to-Consumer Genetic Testing for Dutch Consumers: An in-Depth Content Analysis of Sellers' Websites.
31. Newborn Screening Programmes in Europe, Arguments and Efforts Regarding Harmonisation: Focus on Organic Acidurias
32. A new decade of community genetics: old and new challenges
33. Direct-to-consumer carrier screening for cystic fibrosis via a hospital website: a 6-year evaluation
34. The Gen-Equip Project: evaluation and impact of genetics e-learning resources for primary care in six European languages
35. Moving towards a cure in genetics: what is needed to bring somatic gene therapy to the clinic?
36. Recontacting patients in clinical genetics services: recommendations of the European Society of Human Genetics
37. Genome-wide sequencing in acutely ill infants: genomic medicine’s critical application?
38. Corrigendum to “Effectiveness of L-serine supplementation in children with a GRIN2B loss-of-function mutation: Rationale and protocol for single patient (n-of-1) multiple cross-over trials” [Contemp. Clin. Trials Commun. 36 (2023)/ DOI: 10.1016/j.conctc.2023.101233]
39. Future of Cardiogenetics
40. Recontacting Pediatric Research Participants for Consent When They Reach the Age of Majority
41. Ephedrine treatment for autoimmune myasthenia gravis
42. Chapter 26 - Community and population cardiology
43. Experiences of a High-Risk Population with Prenatal Hemoglobinopathy Carrier Screening in a Primary Care Setting: a Qualitative Study
44. Human germline gene editing: Recommendations of ESHG and ESHRE
45. Responsible innovation in human germline gene editing: Background document to the recommendations of ESHG and ESHRE
46. Older mothers and increased impact of prenatal screening: stable livebirth prevalence of trisomy 21 in the Netherlands for the period 2000–2013
47. One small edit for humans, one giant edit for humankind? Points and questions to consider for a responsible way forward for gene editing in humans
48. Predictive Value of SLCO1B1 c.521T>C Polymorphism on Observed Changes in the Treatment of 1136 Statin-Users
49. Predictive Value of SLCO1B1 c.521T>C Polymorphism on Observed Changes in the Treatment of 1136 Statin-Users
50. Predictive Value of SLCO1B1 c.521T>C Polymorphism on Observed Changes in the Treatment of 1136 Statin-Users.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.